中国机械性眼外伤无光感眼救治专家共识(2020年)

2020-11-20 中华医学会眼科学分会 中华眼科杂志.2020.56(11):815-819.

随着眼外伤救治技术进步和经验不断积累,我国濒危眼外伤的救治水平有了很大提高,既往需要摘除的眼外伤无光感眼,约30%可以获得解剖修复并恢复光感以上视力。探查性玻璃体视网膜手术眼内解剖结构修复理念的提出、

中文标题:

中国机械性眼外伤无光感眼救治专家共识(2020年)

发布日期:

2020-11-20

简要介绍:

随着眼外伤救治技术进步和经验不断积累,我国濒危眼外伤的救治水平有了很大提高,既往需要摘除的眼外伤无光感眼,约30%可以获得解剖修复并恢复光感以上视力。探查性玻璃体视网膜手术眼内解剖结构修复理念的提出、形成和不断推广,已使相当数量的眼外伤无光感眼得到挽救。但由于多种因素制约,在眼外伤无光感眼的救治过程中仍需对Ⅰ期合理处理和Ⅱ期适时眼内解剖修复进行规范化。为了进一步明确并规范复杂眼外伤无光感眼的救治原则和方法,中华医学会眼科学分会眼外伤学组经过反复认真讨论,达成共识性意见,以供眼科医师在临床工作中参考使用。

下载附件:

(因为版权问题,不支持下载)

评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192398, encodeId=91bc11923983b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c5402990, createdName=ms8000000438880791, createdTime=Fri Feb 11 17:46:27 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053545, encodeId=a4c6105354577, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/15/2d46122782343955153dd6dd382f6d5d.jpg, createdBy=ee8e2547691, createdName=向着光, createdTime=Tue Sep 21 18:44:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013120, encodeId=bb35101312032, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 31 09:46:43 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009522, encodeId=eba11009522e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:38 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008550, encodeId=946b100855092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 17 07:12:17 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2022-02-11 ms8000000438880791

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192398, encodeId=91bc11923983b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c5402990, createdName=ms8000000438880791, createdTime=Fri Feb 11 17:46:27 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053545, encodeId=a4c6105354577, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/15/2d46122782343955153dd6dd382f6d5d.jpg, createdBy=ee8e2547691, createdName=向着光, createdTime=Tue Sep 21 18:44:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013120, encodeId=bb35101312032, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 31 09:46:43 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009522, encodeId=eba11009522e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:38 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008550, encodeId=946b100855092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 17 07:12:17 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-09-21 向着光

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192398, encodeId=91bc11923983b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c5402990, createdName=ms8000000438880791, createdTime=Fri Feb 11 17:46:27 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053545, encodeId=a4c6105354577, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/15/2d46122782343955153dd6dd382f6d5d.jpg, createdBy=ee8e2547691, createdName=向着光, createdTime=Tue Sep 21 18:44:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013120, encodeId=bb35101312032, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 31 09:46:43 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009522, encodeId=eba11009522e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:38 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008550, encodeId=946b100855092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 17 07:12:17 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-08-31 眼科芳

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1192398, encodeId=91bc11923983b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c5402990, createdName=ms8000000438880791, createdTime=Fri Feb 11 17:46:27 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053545, encodeId=a4c6105354577, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/15/2d46122782343955153dd6dd382f6d5d.jpg, createdBy=ee8e2547691, createdName=向着光, createdTime=Tue Sep 21 18:44:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013120, encodeId=bb35101312032, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 31 09:46:43 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009522, encodeId=eba11009522e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:38 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008550, encodeId=946b100855092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 17 07:12:17 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-08-19 眼科芳

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1192398, encodeId=91bc11923983b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=142c5402990, createdName=ms8000000438880791, createdTime=Fri Feb 11 17:46:27 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053545, encodeId=a4c6105354577, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/15/2d46122782343955153dd6dd382f6d5d.jpg, createdBy=ee8e2547691, createdName=向着光, createdTime=Tue Sep 21 18:44:35 CST 2021, time=2021-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013120, encodeId=bb35101312032, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 31 09:46:43 CST 2021, time=2021-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009522, encodeId=eba11009522e3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Thu Aug 19 18:24:38 CST 2021, time=2021-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008550, encodeId=946b100855092, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=眼科芳, createdTime=Tue Aug 17 07:12:17 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-08-17 眼科芳

    学习了

    0

拓展阅读

中国眼外伤急诊救治规范专家共识(2019年)

中华医学会眼科学分会 · 2019-09-30

机械性眼外伤导致无光感眼治疗指南(英文)

四川大学华西医院专家组 · 2022-09-23